Discover how the S&P 500 Index performed in 2024 and what that could mean for the first quarter of 2025 according to Barclays ...

Investment firm Barclays laid out its thoughts for the technology space in 2025 in a research note on Thursday, covering ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

BTS member J-Hope reveals his first-ever solo tour, hitting venues in 2025 in North America and Asia for Hope on the Stage ...

In a report released today, Seth Sigman from Barclays maintained a Hold rating on Five Below (FIVE – Research Report), with a price target of ...

Russo also swept our club awards last month, clinching the Goal of the Month and women's Player of the Month accolades. She ...

On Wednesday, Barclays PLC (BCS) stock saw a decline, ending the day at $13.19 which represents a decrease of $-0.06 or -0.45% from the prior close of $13.25. The stock opened at $13.01 and touched a ...

Is the Premier League about to witness the latest triumphant return of Jose Mourinho (actual triumph to be confirmed)? He's ...

MILLENNIUM Management spinoff Modular Asset Management plans to expand to Hong Kong, the latest hedge fund arrival as the ...

We recently published a list of 15 AI Stocks That Skyrocketed in Q4. In this article, we are going to take a look at where ...

Over the past two weeks, few teams have been as hot as the Detroit Pistons. Following another victory, their star player gave ...

Barclays PLC lifted its holdings in shares of Regulus Therapeutics Inc. (NASDAQ:RGLS – Free Report) by 285.2% during the 3rd quarter, Holdings Channel reports. The firm owned 84,477 shares of the ...